A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesPatients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market.Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The company has said it expects to unveil data f...